Drug Samples
Why Not
Datos Bibliográficos
| ID | 15744288 |
|---|---|
| Autores | Ly Le Tran (autor de correspondencia) |
| Año | 2014 |
| Volumen | 16 |
| Número | 4 |
| Páginas | 245-251 |
| Fecha de publicación | 2014-04-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | The AMA Journal of Ethic (JOURNAL) |
| Identificadores de la revista | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Editorial | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/virtualmentor.2014.16.4.ecas2-1404 |
| OpenAlex | W4251488855 |
| Idioma | EN |
| Referencias citadas | 1 |
Case Dr. Williams, the medical director of a large clinic, announces to her staff, “As of next month, we will no longer be offering free drug samples to patients here.” Over the immediate dissent of the doctors, she continues, “I am concerned that, with our limited supply, we are often starting patients on drug regimens that we know we cannot continue to provide for free and that they will not be able to afford once their samples run out.” “This is the only way some of our patients can get their medication!” protests one physician
Business · Dissent · Drug · Medical emergency · Political science · Law · Medicine · Pharmaceutical Practices and Patient Outcomes · Pharmaceutical studies and practices · Pharmacology
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |